Trichloroethylene and parkinsonism: A human and experimental observation

European Journal of Neurology

Volumn 6, Issue 5, 1999, Pages 609-611

  Guehl, Dominique ^a   Bezard, Erwan ^a   Dovero, Sandra ^a   Boraud, Thomas ^a   Bioulac, Bernard ^a   Gross, Christian ^a  

^a CNRS   (France)

Author keywords

Environmental pollution; Parkinson's disease; Trichloroethylene

Indexed keywords

LEVODOPA; TRICHLOROETHYLENE; TYROSINE 3 MONOOXYGENASE;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOREACTIVITY; MALE; MOUSE; NERVE CELL NECROSIS; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

EID: 0033372425     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.1999.650609.x     Document Type: Article

References (25)

1. Agid Y (199l). Parkinson's disease: pathophysiology. Lancet 337:1321-1323.
2. Atkinson A, Mecks RG, Roy D (1993). Increased oxidative stress in the liver of mice treated with trichloroethylene. Biochem Mol Biol Int 31:297-304.
3. Bezard E, Dovero S. Bioulac B, Gross C (1997a). Effect of different schedules of MPTP administration on dopaminergic neurodegeneration in mice. Expt Neurol 148:288-292.
4. Bezard E, Dovero S. Bioulac B. Gross C (1997b). Kinetics of mgral degeneration in a chronic model of MPTP-treated mice Neurosci Letts 234:43-46.
5. Bezard E, Imbert C, Gross CE (1998). Experimental models of Parkinson's disease: from the static to the dynamic. Rev Neurosci 9:71-90.
6. Bowling AC, Beal MF (1995). Bioenergetic and oxidative stress in neurodegenerative diseases. Life Sci 56:1151-1171.
7. Brugnone F, Perbellini L, Giuliari C, Cerpelloni M, Soave M (1994). Blood and urine concentrations of chemical pollutants in the general population. Med Lav 85:370-389.
8. Ehringer H, Hornykiewicz O (1960). Verteilung von Noradrenaiin und Dopumin (3-Hydroxytyramin) im Gehirn des Menschen und ihr Verhalten bei Erkrankungen des extra-pyramidalen Systems. Klin Wochenschr 38:1236-1239.
9. Fahn S, Elton RL, Committee MotUD (1987). Unified Parkinson's Disease Rating Scale. In: Recent Developments in Parkinson's Disease editors S Fahn and CD Marsden. Florham Park, Macmillan Health Care. pp 153-164.
10. Fearnley JM, Lees AJ (1991). Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain 114:2283-2301.
11. Grcevic N, Jadro-Santel D, Jukie S (1977). Cerebral changes in paraquat poisoning. In: Neurotoxicology editors L Roizin, H Shiraki and N Grcevic. New York, Raven Press. pp 468-484.
12. Gross C, Rougier A, Guehl D, Boraud T, Julien J, Bioulac B (1997). High frequency stimulation of the globus pallidus internalis in Parkinson's disease: a seven-case study. J Neurosurg 87:491-498.
13. Hirsch EC (1994). Biochemistry of Parkinson's disease with special reference to the dopaminergic systems. Molec Neurobiol 9:135-142.
14. Hochn HM, Yahr MD (1967). Parkinsonism: onset, progression and mortality. Neurology 17:427-442.
15. Jackson-Lewis V, Jakowec M, Burke RE, Przedborski S (1995). Time course and morphology of dopaminergic neuronal death caused by the neurotoxin l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Neurodegeneration 4:257-269.
16. Langston JW, Widner H, Goetz CG, Brooks D, Fahn S, Freeman T, Watts R (l992). Core assessment program for intracerebral transplantations (CAPIT), Move Disord 7:2-13.
17. Masalha R, Herishanu Y, Alfahed-Kakunda A, Silverman WF (1997). Selective dopamine neurotoxicity by an industrial chemical: an environmental cause of Parkinson's disease? Brain Res 774:260-264.
18. Morrish PK, Sawle GV, Brooks DJ (1996). An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. Brain 119:585-591.
19. Nelson EL, Liang CL, Sinton CM, German DC (1996). Midbrain dopaminergic neurons in the mouse: computer-assisted mapping. J Comp Neurol 369:361-371.
20. Obata T, Chiueh CC (1992). In vivo trapping of hydroxyl radical free radicals in the striatum utilizing intracranial microdialysis perfusion of salicylate: effects of MPTP, MPDP+, and MPP. J Neural Transm 89:139-145.
21. Pezzoli G, Barbieri S, Ferrante C, Zeechinelli A (1989). Parkinsonism due to n-hexane exposure. Lancet 874.
22. Pezzoli G, Riceiardi S, Masotto C, Mariani CB, Carenzi A (1990), N-hexane induces parkinsonism in rodents. Brain Res 531:355-337.
23. Sachs CH, Jonsson G (1975). Mechanisms of action of 6-hydroxydopamine. Biochem Pharmacol 24:1-8.
24. Spencer PS. Ludolph AC, Kisby CE (1992). Are human neurodegenerative disorders linked to environmental chemicals with excitotoxic properties. Ann N-Y Acad Sci 648:154-160.
25. Vingerhoets FJG, Snow BJ, Lee CS, Schulzer M, Mak E, Calne DB (1994). Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathie parkinsonism. Ann. Neurol 36:759-764.